3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
6
Colorectal Neoplasms
3
Osteosarcoma
2
Neoplasms
2
Wilms Tumor
1
Small Bowel Adenocarcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Rectal Cancer Patients
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasm Metastasis
1
Metastatic Gastric Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Hepatoblastoma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Advanced Rectal Cancer
1
Interventions
Letrozole
4
Fulvestrant
4
trastuzumab deruxtecan
2
toripalimab
2
elacestrant
2
Injections
2
Anastrozole
2
AZD9833
2
ribociclib
1
palbociclib
1
exemestane
1
disitamab vedotin
1
abemaciclib
1
Selective Estrogen Receptor Modulators
1
Ritonavir
1
RAD1901
1
Paclitaxel
1
Lead
1
Itraconazole
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Everolimus
1
Alpelisib
1
AZD5305
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Breast Cancer
×
irinotecan sucrosofate
×
90 days
×
Clear all
No trials found.